Key terms

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BLRX news

May 17 6:27pm ET BioLineRx Faces Nasdaq Compliance Challenge by TipRanks May 17 5:01pm ET BioLineRx receives Nasdaq minimum bid price notification by TipRanks May 06 7:57am ET BioLineRx Reveals Cost-Saving Stem Cell Mobilization Data by TipRanks Apr 17 11:05am ET Buy Rating on Bioline RX Ltd for Breakthrough Stem Cell Mobilization and Enhanced Apheresis Efficiency by TipRanks Apr 17 8:27am ET BioLineRx Enhances Multiple Myeloma Treatment by TipRanks Apr 01 11:27am ET BiolineRx Ltd. Completes Significant Securities Offering by TipRanks Apr 01 9:05am ET BioLineRx to sell 7.5M ADSs at 80c in registered direct offering by TipRanks Mar 28 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 26 11:45am ET Buy Rating Affirmed for BioLineRx: Strong Financials and Expanding Market Presence Fuel Analyst Optimism by TipRanks Mar 26 8:05am ET Options Volatility and Implied Earnings Moves Today, March 26, 2024 by TipRanks Mar 26 7:59am ET BioLineRx Announces Major Commercial Milestones by TipRanks Mar 25 8:00am ET Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024 by TipRanks Mar 04 7:12am ET BioLineRx receives Notice of Allowance from USPTO for a patent by TipRanks Feb 29 6:27am ET Positive Outlook for Bioline RX with Promising Phase 2 Trial Results and New Product Launch: A Buy Rating by TipRanks Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 28 7:22am ET BioLineRx announces dosing of frist patient in CheMo4METPANC Phase 2 trial by TipRanks

No recent press releases are available for BLRX

BLRX Financials

1-year income & revenue

Key terms

BLRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BLRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

The Red Lobster logo is displayed outside of a closed restaurant in Torrance, California on May 14, 2024. Dozens of Red Lobster locations were listed as "temporarily closed" on the Red Lobster website, while equipment from "over 50 locations" went up for auction, TAGeX Brands, the company conducting the online auction, announced on May 13, 2024.
Patrick T. Fallon/AFP/Getty Images
Red Lobster files for bankruptcy
Ivan Boesky leaves courthouse after pleading guilty to a count of conspiracy on April 24, 1987.
Keith Torrie/NY Daily News/Getty Images
Ivan Boesky, famed trader in 1980s insider trading scandal, dies at 87
Will the Fed lower interest rates in September? That's the billion dollar question.
Chip Somodevilla/Getty Images
Why Jay Powell really wants to lower interest rates this September
Dave Calhoun, chief executive officer of Boeing Co., center right, on Capitol Hill in Washington, DC, US, on Wednesday, Jan. 24, 2024. The company is working to assure airline customers and the Federal Aviation Administration that its jets are safe after a January 5 accident, which involved a faulty door panel on a 737 Max 9 aircraft operated by Alaska Airlines.
Samuel Corum/Bloomberg/Getty Images
Boeing shareholders vote to approve $33 million CEO pay package